SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,363,041 | -34.0% | 1,538,421 | +17.0% | 0.00% | – |
| Q3 2022 | $2,064,000 | -15.1% | 1,314,634 | +8.7% | 0.00% | -100.0% |
| Q2 2022 | $2,430,000 | +5.8% | 1,209,139 | +22.7% | 0.00% | – |
| Q1 2022 | $2,297,000 | -48.4% | 985,502 | +2.8% | 0.00% | -100.0% |
| Q4 2021 | $4,455,000 | -49.8% | 958,261 | -17.6% | 0.00% | -50.0% |
| Q3 2021 | $8,869,000 | -9.7% | 1,162,385 | +14.7% | 0.00% | 0.0% |
| Q2 2021 | $9,818,000 | +30.7% | 1,013,177 | +11.6% | 0.00% | 0.0% |
| Q1 2021 | $7,511,000 | +18.5% | 908,251 | -2.2% | 0.00% | +100.0% |
| Q4 2020 | $6,337,000 | -24.8% | 928,428 | +22.9% | 0.00% | -50.0% |
| Q3 2020 | $8,423,000 | +107.4% | 755,438 | +16.8% | 0.00% | +100.0% |
| Q2 2020 | $4,061,000 | +435.8% | 646,704 | +56.9% | 0.00% | – |
| Q1 2020 | $758,000 | -44.6% | 412,097 | +1.9% | 0.00% | – |
| Q4 2019 | $1,367,000 | +47.6% | 404,464 | -6.5% | 0.00% | – |
| Q3 2019 | $926,000 | -23.5% | 432,528 | -4.5% | 0.00% | – |
| Q2 2019 | $1,210,000 | -41.6% | 453,057 | +3.9% | 0.00% | -100.0% |
| Q1 2019 | $2,071,000 | +104.2% | 436,151 | +3.2% | 0.00% | – |
| Q4 2018 | $1,014,000 | -42.0% | 422,451 | +6.3% | 0.00% | – |
| Q3 2018 | $1,749,000 | -22.3% | 397,366 | +27.2% | 0.00% | -100.0% |
| Q2 2018 | $2,250,000 | +637.7% | 312,419 | +429.0% | 0.00% | – |
| Q1 2018 | $305,000 | +47.3% | 59,059 | +8.2% | 0.00% | – |
| Q4 2017 | $207,000 | +263.2% | 54,598 | +62.8% | 0.00% | – |
| Q3 2017 | $57,000 | +1.8% | 33,534 | +20.2% | 0.00% | – |
| Q2 2017 | $56,000 | -90.5% | 27,888 | -81.3% | 0.00% | – |
| Q1 2017 | $590,000 | -19.6% | 149,424 | -0.2% | 0.00% | – |
| Q4 2016 | $734,000 | -15.1% | 149,755 | +34.1% | 0.00% | – |
| Q3 2016 | $865,000 | +31.1% | 111,703 | -5.2% | 0.00% | – |
| Q2 2016 | $660,000 | +3.9% | 117,846 | -0.0% | 0.00% | – |
| Q1 2016 | $635,000 | -18.7% | 117,891 | +31.5% | 0.00% | – |
| Q4 2015 | $781,000 | -0.1% | 89,643 | -3.8% | 0.00% | – |
| Q3 2015 | $782,000 | -74.0% | 93,204 | -45.4% | 0.00% | -100.0% |
| Q2 2015 | $3,008,000 | +1103.2% | 170,723 | +689.0% | 0.00% | – |
| Q1 2015 | $250,000 | +60.3% | 21,639 | +39.4% | 0.00% | – |
| Q4 2014 | $156,000 | +194.3% | 15,521 | +32.5% | 0.00% | – |
| Q3 2014 | $53,000 | -66.5% | 11,716 | -50.0% | 0.00% | – |
| Q2 2014 | $158,000 | – | 23,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |